Mack P - Search Results

1

Molecular-clinical correlative studies in non-small cell lung cancer: application of a three-tiered approach.

Gandara DR, Lara PN, Lau DH, Mack P, Gumerlock PH. Gandara DR, et al. Among authors: mack p. Lung Cancer. 2001 Dec;34 Suppl 3:S75-80. doi: 10.1016/s0169-5002(01)00368-3. Lung Cancer. 2001. PMID: 11740998 Review. No abstract available.

2

Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression.

DeNardo SJ, Gumerlock PH, Winthrop MD, Mack PC, Chi SG, Lamborn KR, Shen S, Miers LA, deVere White RW, DeNardo GL. DeNardo SJ, et al. Among authors: mack pc. Cancer Res. 1995 Dec 1;55(23 Suppl):5837s-5841s. Cancer Res. 1995. PMID: 7493356

3

Decreased C-MYC and BCL2 expression correlates with methylprednisolone-mediated inhibition of Raji lymphoma growth.

Morris G, DeNardo SJ, DeNardo GL, Leshchinsky T, Wu B, Mack PC, Winthrop MD, Gumerlock PH. Morris G, et al. Among authors: mack pc. Biochem Mol Med. 1997 Apr;60(2):108-15. doi: 10.1006/bmme.1997.2568. Biochem Mol Med. 1997. PMID: 9169090

4

Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade.

Mack PC, Chi SG, Meyers FJ, Stewart SL, deVere White RW, Gumerlock PH. Mack PC, et al. Prostate. 1998 Feb 1;34(2):145-51. doi: 10.1002/(sici)1097-0045(19980201)34:2<145::aid-pros10>3.0.co;2-i. Prostate. 1998. PMID: 9465946

5

Overexpression of cyclin D1 is rare in human prostate carcinoma.

Gumbiner LM, Gumerlock PH, Mack PC, Chi SG, deVere White RW, Mohler JL, Pretlow TG, Tricoli JV. Gumbiner LM, et al. Among authors: mack pc. Prostate. 1999 Jan 1;38(1):40-5. doi: 10.1002/(sici)1097-0045(19990101)38:1<40::aid-pros5>3.0.co;2-i. Prostate. 1999. PMID: 9973108

6

RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.

Mack PC, Gandara DR, Bowen C, Edelman MJ, Paglieroni T, Schnier JB, Gelmann EP, Gumerlock PH. Mack PC, et al. Clin Cancer Res. 1999 Sep;5(9):2596-604. Clin Cancer Res. 1999. PMID: 10499638

7

Kroger LA, DeNardo GL, Gumerlock PH, Xiong CY, Winthrop MD, Shi XB, Mack PC, Leshchinsky T, DeNardo SJ. Kroger LA, et al. Among authors: mack pc. Cancer Biother Radiopharm. 2001 Jun;16(3):213-25. doi: 10.1089/10849780152389401. Cancer Biother Radiopharm. 2001. PMID: 11471486

8

Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial.

Lara PN Jr, Gandara DR, Longmate J, Gumerlock PH, Lau DH, Edelman MJ, Gandour-Edwards R, Mack PC, Israel V, Raschko J, Frankel P, Perez EA, Lenz HJ, Doroshow JH. Lara PN Jr, et al. Among authors: mack pc. Cancer Chemother Pharmacol. 2001 Jul;48(1):22-8. doi: 10.1007/s002800100293. Cancer Chemother Pharmacol. 2001. PMID: 11488520 Clinical Trial.

9

Docetaxel in non-small cell lung cancer: a review.

Davies AM, Lara PN Jr, Mack PC, Gandara DR. Davies AM, et al. Expert Opin Pharmacother. 2003 Apr;4(4):553-65. doi: 10.1517/14656566.4.4.553. Expert Opin Pharmacother. 2003. PMID: 12667118 Review.

10

Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma.

Mack PC, Gandara DR, Lau AH, Lara PN Jr, Edelman MJ, Gumerlock PH. Mack PC, et al. Cancer Chemother Pharmacol. 2003 Apr;51(4):337-48. doi: 10.1007/s00280-003-0571-6. Epub 2003 Mar 25. Cancer Chemother Pharmacol. 2003. PMID: 12721762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters